Journal of Pharmaceutical Research

The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off


Proniosmal gel of clonazepam (CNZ) for transdermal delivery to provide controlled drug release was prepared by phase coacervation method using non ionic surfactants, cholesterol and egg lecithin. The formulations were investigated for surface morphology by scanning electron microscopy (SEM), particle size, entrapment efficiency, in-vitro drug release and in-vitro drug permeation. SEM enabled visualization of proniosomes of clonazepam and the vesicle size was found to be in the range of 1492.32 - 9865.68 nm with entrapment efficiency as high as 72.9%. Amongst the ten formulations designed, F2 and F6 were selected as the optimized formulations and incorporation of egg lecithin increased the entrapment efficiency of the selected formulations to more than 90%. The fabricated matrix transdermal patch exhibited more than 70% drug release in 24 hours.

Keywords

Clonazepam, Proniosomes, Transdermal Delivery, In Vitro Permeation.
User
Notifications
Font Size